Wholesale Peptides Philippines: Bulk Guide

A search for "peptide wholesale price list philippines" returns retail catalogues, Shopee and Lazada reseller listings, and telehealth operations that gate price behind a consultation. It does not return a table of quantity breaks. Business pricing in this market is quoted privately.

That absence is easy to read as evasion. The two commercial reasons behind it are worth understanding first, because both affect how a bulk buyer negotiates.

A published tier is a target.A seller who holds no stock carries no inventory cost, no cold-chain overhead and no capital tied up in vials sitting in a fridge in Metro Manila. That seller can read a published tier, undercut it by a small margin, take the order, and only then place it upstream with the customer's money. Publishing a number hands the least-committed operators in the market a floor to shoot at, and the buyer who chases it is the one left waiting for a parcel.

A tier written for the average buyer fits nobody. The real per-vial number moves on compound mix, order cadence, whether the buyer takes one dispatch or a standing monthly draw, whether the packaging is plain or own-label, and whether an invoice is needed. Twelve vials of GHK-Cu and twelve vials of retatrutide are different amounts of money and different amounts of risk to hold. A single printed grid either overprices the small mixed order or underprices the large single-SKU one, and in practice it does both.

A bulk quote cannot be judged without a retail anchor, and the useful anchor is a published Philippine catalogue in pesos rather than a converted overseas figure. Below is the per-vial retail pricing listed by our partner and supplier Primara Labs. Business pricing is set against this per account, in the enquiry, rather than printed.

The right-hand column is the retail price after the standing 10% discount that applies to every order. It is not a bulk tier. This site publishes no Primara wholesale tier, minimum order, margin or percentage beyond that standing discount; business terms are set per account in the WhatsApp enquiry.

Note the spread across the catalogue. GHK-Cu at ₱1,325 and retatrutide at ₱3,775a vial are not the same procurement problem, and a supplier who quotes the same shape across both is quoting a policy rather than reading its own stock position. Line-by-line pricing against the buyer's actual mix is the signal worth looking for. The full catalogue with per-milligram figures sits in the PH peptide price index.

Most bulk buyers frame this as a unit price question. It is a cash cycle question, and the unit price is the smallest of the three variables in it.

Importing means money leaves the account on day zero and the goods arrive after international transit and customs clearance, assuming nothing is detained. Buying local stock means money leaves the account and the vials are in the fridge the same afternoon. On the same capital, the second model turns more times per year, and it does so without anyone having to predict demand a month out.

Before accepting an import quote, three things need pricing rather than one: the per-vial saving, the cost of the extra idle capital across a year of cycles, and the expected value of the shipment that does not arrive. First-time bulk buyers tend to price the first and quietly assume the other two are zero.

Under RA 9711 a drug must be registered with FDA Philippines before it is imported, sold or distributed. Research peptides are not registered medicines. What that means for an individual parcel is set out in the regulation hub, the FDA Philippines regulation filing and the legality filing.

Volume changes how a parcel reads: identical vials in quantity, repeat consignments to the same address, or a declared value that no individual would plausibly self-fund. Once a parcel reads commercial, the questions change with it. Who is the importer of record. Is the declared valuation defensible. Are these registered products.

A domestic transaction has no international leg, which removes the customs stage and the longest stretch of unmanaged heat exposure. It does not change the registration position, which is the same for every route.

One vial is a fridge shelf. Thirty vials is inventory, and inventory needs a written rule rather than a habit. The science does not get harder. A single unnoticed failure now writes off a whole position instead of one vial.

Five things belong in place before the first bulk parcel arrives. First, a dedicated fridge, not the staff fridge that gets opened forty times a day. Second, a min/max recording thermometer, the only way to know whether an excursion happened while nobody was watching. Third, a brownout plan: a Metro Manila condo or clinic fridge that loses power overnight is a genuine cold-chain break, and no test run afterwards can confirm the stock survived. Fourth, batch numbers logged against a received date on arrival, so that a problem can be quarantined to one batch instead of the whole holding. Fifth, first in first out, written down, because at thirty vials nobody remembers which box came when.

The receiving window is where breaks tend to happen. An insulated bulk parcel that sits in a building reception for four hours has had a worse afternoon than a well-packed courier leg. A named person should receive it, and the supplier should have that person's name and number rather than a generic front desk.

Every supplier in this market says it can supply. Some mean they hold stock; others mean they can order it. The distinction is invisible in a catalogue and obvious under pressure, so the pressure belongs before money is committed rather than after.

The test: ask for a same-day delivery on a named SKU, on a weekday morning, inside Metro Manila. Not a quote. A delivery. A supplier who holds local stock gives one of two clean answers. Either yes, with a confirmation cut-off time attached, or no, that SKU is out, and here is the restock date. Both answers are useful, and both are only available to someone who can see their own fridge.

A drop-shipper cannot produce either answer, and the substitutes are consistent enough to be diagnostic: "let me check with the lab", a batch that lands soon, a two to three week window that never shortens. Often a discount arrives unprompted, because price is the only thing a drop-shipper can adjust, and the discount is really compensation for a wait not yet admitted to.

Neither model is illegitimate. Drop-shipping can serve a hobbyist buying one vial a quarter who does not mind the wait. It is a bad fit for anyone with a schedule to keep, because the lead time and the cold chain both belong to someone else. For a buyer reselling or holding against bookings, the question is not who is cheapest. It is who can be wrong about demand and still deliver on Thursday.

This is the question that separates buying for a business from buying for oneself, and it is often raised too late. A purchase that has to appear in the books as a supported expense needs an official sales invoice from a BIR-registered seller, issued in the registered business name, with a line description the business is comfortable defending. For a VAT-registered buyer, that document also supports input VAT. Without it the cost either sits outside the books entirely or sits inside them with nothing behind it, and the second is worse than the first.

A large part of this market operates informally over chat. For an individual buyer that is unremarkable. For a company, a clinic or a reseller it is a structural problem that does not resolve itself. Four questions belong in the first message rather than after delivery:

• Is the seller BIR registered, and can it issue an official sales invoice.
• In what name will the invoice be issued, and can it carry the buyer's TIN.
• How will the goods be described on the invoice line, and does that description work in the buyer's own records.
• What payment channels are accepted, and does the receiving account match the invoicing entity.

That last point does more work than it looks like. A supplier who can only take payment into a personal e-wallet and cannot issue anything is not necessarily dishonest, but it is saying plainly what kind of counterparty it is set up to be. That fit is worth deciding before thirty vials of its stock and a reconciliation problem arrive.

Primara ordering runs over WhatsApp with no checkout and no forms, so invoicing arrangements are part of the enquiry conversation rather than something a cart decides. It belongs in the first message.

Because pricing in this market is quoted rather than published, the quality of the enquiry determines how long a figure takes. A vague message buys three rounds of clarifying questions. A specific message can return a number the same day, because it removes every reason for the supplier to ask something first.

Seven things to include, in roughly this order:

• Who the buyer is and what the volume is for, in one line.
• Exact SKUs and vial sizes. "Retatrutide 20mg", not "retatrutide".
• Quantity per SKU. A real number, not a range left open to negotiation.
• Whether this is a one-time order or recurring, and at what cadence if recurring.
• Delivery city and district, and whether same-day matters.
• Invoicing requirement, stated up front rather than discovered at delivery.
• Packaging requirement: plain outer packaging or own label, and the decision timeline.

A good reply gives a per-vial figure against each stated SKU at the stated quantity, a dispatch date, and a straight answer on invoicing. A poor reply asks what the budget is, or returns a price band with no quantity attached. The first is a supplier reading its stock. The second is a supplier reading the buyer.

Clinic supply is a different conversation with different constraints, covered in the clinic sourcing guide. Own-label supply sits on the private label page.